Adverse Childhood Experiences in Substance-related Disorders
Stress Sensitivity, Emotion Processing and Cue-reactivity: the Influence of Adverse Childhood Experiences in Substance-related Disorders
1 other identifier
observational
70
1 country
1
Brief Summary
Aversive childhood experiences (ACE) and their relation to the development of an alcohol use disorder will be measured with fMRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2018
CompletedFirst Posted
Study publicly available on registry
November 29, 2018
CompletedStudy Start
First participant enrolled
December 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedJuly 29, 2021
July 1, 2021
2.4 years
August 20, 2018
July 28, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
fMRI to assess group differences in task-specific brain activation patterns: Stress-sensitivity
Stress-sensitivity: stress task (e.g.mental rotation with and without time pressure) with social component within the MRI scanner to assess neural activation patters during the stress-task
fMRI measurement at one day only (day of fMRI experiment)
fMRI to assess group differences in task-specific brain activation patterns: Emotion processing
Emotion-processing: emotional face-/form-matching task to assess neural activation patters of emotion processing
fMRI measurement at one day only (day of fMRI experiment)
fMRI to assess group differences in task-specific brain activation patterns: Alcohol cue-reactivity
Alcohol cue-reactivity: pictures of alcoholic beverages to asses neural alcohol-cue reactivity
fMRI measurement at one day only (day of fMRI experiment)
Secondary Outcomes (3)
Hormonal stress response using salivary cortisol level
Normal awakening response on a subject's regular week-day (0, 0.5, 8 and 14 hours after wake-up)
Hormonal stress response using salivary cortisol level
Stress response during the fMRI stress task (day of fMRI experiment, at -45, -22, -10 minutes before and 35, 45, 60, 75 and 90 minutes after onset of stress induction)
GWAS and especially glutamatergic, serotonergic single-nucleotide polymorphisms
blood sample at one day only (day of fMRI experiment)
Study Arms (3)
Individuals with alcohol use disorder + ACE
Individuals with AUD and varying levels of adverse childhood experiences (ACE)
Healthy controls
Healthy individuals without AUD
Individuals with alcohol use disorder, no ACE
Individuals with AUD and no adverse childhood experiences (ACE)
Interventions
No intervention
Eligibility Criteria
Residents from Mannheim/ Heidelberg who answered an open call to participate in this study
You may qualify if:
- male and female
- age between 18 and 65
- normal or correctable eyesight
- Sufficient ability to communicate with the investigators, to answer questions in oral and written form
- "Fully Informed Consent"
- "Written Informed Consent"
- Healthy individuals (AUDIT Score\<=8, alcohol intake \< 12g/ less than 5 days (women) \& 24g/ less than 5 days (men)
- Individuals with alcohol use disorder according to DSM-5 or 'heavy drinking' (alcohol intake \> 40g/ more than 5 days (women) \& 60g/ more than 5 days (men) with up to 28 days of abstinence AND aversive childhood experiences
You may not qualify if:
- Withdrawal of the declaration of consent
- severe internal, neurological and psychiatric comorbidities
- Pharmacotherapy with psychoactive substances within the last 14 days (except treatment with SSRI/SNRIs for at least 28 days)
- Axis-I disorder according to ICD-10 and DSM 5 (except tobacco and alcohol use disorder, substance abuse with less than 2(11) criteria according to DSM-5, mild depressive episode, adaptation disorder and specific phobia within the last 12 months)
- positive urin drug screening (cannabis, amphetamine, opiates, benzodiazepines, cocaine)
- withdrawal symptoms (CIWA-R \> 7)
- intoxication at time of investigation (breathalyzer \> 0.3‰)
- suicidal tendency or potential danger for others
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
Mannheim, Germany
Related Publications (1)
Gerhardt S, Berhe O, Moessnang C, Horning M, Kiefer F, Tost H, Vollstadt-Klein S. Lack of amygdala habituation to negative emotional faces in alcohol use disorder and the relation to adverse childhood experiences. Addict Biol. 2023 Jan;28(1):e13251. doi: 10.1111/adb.13251.
PMID: 36577733DERIVED
Biospecimen
Saliva (stress hormones) Blood (genotyping)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine Vollstaedt-Klein
CIMH Mannheim
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2018
First Posted
November 29, 2018
Study Start
December 15, 2018
Primary Completion
May 27, 2021
Study Completion
August 31, 2021
Last Updated
July 29, 2021
Record last verified: 2021-07